Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0689
G

Failure to Prevent Falls in Resident Receiving Psychotropic Medication

Dillon, Montana Survey Completed on 05-08-2025

Penalty

Fine: $74,560
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to identify and implement effective interventions to prevent further falls for a resident with dementia, limited safety awareness, and a known risk for falls. The resident was prescribed psychotropic medications, specifically Ativan, which was recently increased in dosage. Despite the resident's history and increased risk, the care plan contained only minimal fall interventions. The resident experienced multiple unwitnessed falls, including one resulting in head lacerations, and the facility's investigation did not consider the recent increase in Ativan dosage as a contributing factor. Subsequent documentation showed that the resident continued to have increased falls after the Ativan dose was raised, ultimately sustaining a fractured hip. Staff interviews confirmed that the Ativan contributed to the resident's falls and that the medication was not appropriate for the resident's needs. The decrease in Ativan dosage occurred only after the resident had already suffered a serious injury. The facility's lack of comprehensive assessment and timely intervention in response to the resident's changing condition and medication regimen led to repeated falls and significant harm.

An unhandled error has occurred. Reload 🗙